• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 修饰作为新兴的治疗靶点。

RNA modifications as emerging therapeutic targets.

机构信息

Vocational Health College, Canakkale Onsekiz Mart University, Canakkale, Turkey.

Akershus Universitetssykehus, Medical Department, Lørenskog, Norway.

出版信息

Wiley Interdiscip Rev RNA. 2022 Jul;13(4):e1702. doi: 10.1002/wrna.1702. Epub 2021 Nov 23.

DOI:10.1002/wrna.1702
PMID:34816607
Abstract

The field of epitranscriptome, posttranscriptional modifications to RNAs, is still growing up and has presented substantial evidences for the role of RNA modifications in diseases. In terms of new drug development, RNA modifications have a great promise for therapy. For example, more than 170 type of modifications exist in various types of RNAs. Regulatory genes and their roles in critical biological process have been identified and they are associated with several diseases. Current data, for example, identification of inhibitors targeting RNA modifications regulatory genes, strongly support the idea that RNA modifications have potential as emerging therapeutic targets. Therefore, in this review, RNA modifications and regulatory genes were comprehensively documented in terms of drug development by summarizing the findings from previous studies. It was discussed how RNA modifications or regulatory genes can be targeted by altering molecular mechanisms. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications RNA Processing > RNA Editing and Modification.

摘要

表观转录组学领域,即 RNA 的转录后修饰,仍在不断发展,并为 RNA 修饰在疾病中的作用提供了大量证据。就新药开发而言,RNA 修饰在治疗方面具有很大的前景。例如,在各种类型的 RNA 中存在超过 170 种类型的修饰。调控基因及其在关键生物过程中的作用已被确定,并与多种疾病相关。例如,目前已经鉴定出针对 RNA 修饰调控基因的抑制剂,这些发现强烈支持 RNA 修饰作为新兴治疗靶点的潜力。因此,在这篇综述中,通过总结以前研究的结果,从药物开发的角度全面记录了 RNA 修饰和调控基因。讨论了如何通过改变分子机制来靶向 RNA 修饰或调控基因。本文属于以下分类:RNA 在疾病和发育中的作用 > RNA 在疾病中 RNA 与蛋白质和其他分子的相互作用 > 蛋白质-RNA 相互作用:功能意义 RNA 加工 > RNA 编辑和修饰。

相似文献

1
RNA modifications as emerging therapeutic targets.RNA 修饰作为新兴的治疗靶点。
Wiley Interdiscip Rev RNA. 2022 Jul;13(4):e1702. doi: 10.1002/wrna.1702. Epub 2021 Nov 23.
2
The pivotal regulatory landscape of RNA modifications.RNA修饰的关键调控格局。
Annu Rev Genomics Hum Genet. 2014;15:127-50. doi: 10.1146/annurev-genom-090413-025405. Epub 2014 Jun 2.
3
The emerging role of epitranscriptome in shaping stress responses in plants.外转录组在塑造植物应激反应中的新兴作用。
Plant Cell Rep. 2023 Oct;42(10):1531-1555. doi: 10.1007/s00299-023-03046-1. Epub 2023 Jul 23.
4
The role of mA, mC and Ψ RNA modifications in cancer: Novel therapeutic opportunities.mA、mC 和 Ψ RNA 修饰在癌症中的作用:新的治疗机会。
Mol Cancer. 2021 Jan 18;20(1):18. doi: 10.1186/s12943-020-01263-w.
5
Adenosine-to-Inosine RNA Editing in Health and Disease.腺苷到肌苷 RNA 编辑在健康和疾病中的作用。
Antioxid Redox Signal. 2018 Sep 20;29(9):846-863. doi: 10.1089/ars.2017.7295. Epub 2017 Sep 26.
6
Adenosine-to-inosine RNA editing.腺嘌呤核苷到次黄嘌呤核苷 RNA 编辑。
Wiley Interdiscip Rev Syst Biol Med. 2009 Sep-Oct;1(2):202-209. doi: 10.1002/wsbm.10.
7
Emerging roles of the epitranscriptome in parasitic protozoan biology and pathogenesis.表观转录组在寄生原生动物生物学和发病机制中的新作用。
Trends Parasitol. 2024 Mar;40(3):214-229. doi: 10.1016/j.pt.2024.01.006. Epub 2024 Feb 13.
8
The interplay between m6A RNA methylation and noncoding RNA in cancer.m6A RNA 甲基化与癌症中非编码 RNA 的相互作用。
J Hematol Oncol. 2019 Nov 22;12(1):121. doi: 10.1186/s13045-019-0805-7.
9
RNA modifications and cancer.RNA 修饰与癌症。
RNA Biol. 2020 Nov;17(11):1560-1575. doi: 10.1080/15476286.2020.1722449. Epub 2020 Feb 7.
10
Epitranscriptome in action: RNA modifications in the DNA damage response.表观转录组学的作用:DNA 损伤反应中的 RNA 修饰。
Mol Cell. 2024 Oct 3;84(19):3610-3626. doi: 10.1016/j.molcel.2024.09.003.

引用本文的文献

1
Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.环境毒素诱导的表观转录组改变:对RNA修饰和疾病的影响。
Genes Environ. 2025 Aug 4;47(1):14. doi: 10.1186/s41021-025-00337-9.
2
Multimodal zero-shot learning of previously unseen epitranscriptomes from RNA-seq data.从RNA测序数据中对以前未见过的表观转录组进行多模态零样本学习。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf332.
3
RNA Modification in Metabolism.新陈代谢中的RNA修饰
MedComm (2020). 2025 Mar 10;6(3):e70135. doi: 10.1002/mco2.70135. eCollection 2025 Mar.
4
A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitors.一种基于微尺度热泳的酶促RNA甲基转移酶检测方法能够发现DNA甲基转移酶2(DNMT2)抑制剂。
Commun Chem. 2025 Feb 3;8(1):32. doi: 10.1038/s42004-025-01439-9.
5
Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation.单细胞表观转录组学的统计建模实现了RNA甲基化的轨迹和调控推断。
Cell Genom. 2025 Jan 8;5(1):100702. doi: 10.1016/j.xgen.2024.100702. Epub 2024 Dec 5.
6
Epigenetic control of dental stem cells: progress and prospects in multidirectional differentiation.牙干细胞的表观遗传调控:多向分化的研究进展与前景
Epigenetics Chromatin. 2024 Dec 3;17(1):37. doi: 10.1186/s13072-024-00563-5.
7
RNA modification regulators as promising biomarkers in gynecological cancers.RNA 修饰调节因子作为妇科癌症有前途的生物标志物。
Cell Biol Toxicol. 2024 Oct 29;40(1):92. doi: 10.1007/s10565-024-09924-y.
8
Clinician's Guide to Epitranscriptomics: An Example of N-Methyladenosine (mA) RNA Modification and Cancer.表观转录组学临床医生指南:以N-甲基腺苷(m⁶A)RNA修饰与癌症为例
Life (Basel). 2024 Sep 25;14(10):1230. doi: 10.3390/life14101230.
9
Acetylcytidine modification of DDX41 and ZNF746 by -acetyltransferase 10 contributes to chemoresistance of melanoma.乙酰转移酶10对DDX41和ZNF746的乙酰胞苷修饰有助于黑色素瘤的化疗耐药性。
Front Oncol. 2024 Aug 23;14:1448890. doi: 10.3389/fonc.2024.1448890. eCollection 2024.
10
Writers, readers, and erasers RNA modifications and drug resistance in cancer.RNA 修饰与癌症的药物耐药性:作者、读者和橡皮擦
Mol Cancer. 2024 Aug 30;23(1):178. doi: 10.1186/s12943-024-02089-6.